-
2
-
-
0021759840
-
Gingival hyperplasia induced by cyclosporin-A
-
Tyldesley WR, Rotter E. Gingival hyperplasia induced by cyclosporin-A. Br Dent J 1984; 157: 305-309
-
(1984)
Br Dent J
, vol.157
, pp. 305-309
-
-
Tyldesley, W.R.1
Rotter, E.2
-
3
-
-
0026030596
-
The effect of plaque control programme on the incidences and severity of cyclosporin induced gingival changes
-
Seymour RA, Smith DG. The effect of plaque control programme on the incidences and severity of cyclosporin induced gingival changes. J Clin Periodontol 1991; 18: 107-110
-
(1991)
J Clin Periodontol
, vol.18
, pp. 107-110
-
-
Seymour, R.A.1
Smith, D.G.2
-
4
-
-
0028930354
-
Improvement in cyclosporine-associated gingival hyperplasia with azithromycin therapy
-
Wahlstrom E, Zamora JU,Teichman S. Improvement in cyclosporine-associated gingival hyperplasia with azithromycin therapy. N Engl J Med 1995; 332: 753-754
-
(1995)
N Engl J Med
, vol.332
, pp. 753-754
-
-
Wahlstrom, E.1
Zamora, J.U.2
Teichman, S.3
-
5
-
-
0030160236
-
Index to measure gingival bleeding
-
Newbrun E. Index to measure gingival bleeding. J Periodontal 1996; 67: 555-561
-
(1996)
J Periodontal
, vol.67
, pp. 555-561
-
-
Newbrun, E.1
-
6
-
-
0029142565
-
Prevalence of severity of nifedipine-induced gingival overgrowth
-
Nery EB, Fdson RG, Lee KK, Pruthi VK, Watson J. Prevalence of severity of nifedipine-induced gingival overgrowth. J Periodontol 1995; 66: 572-578
-
(1995)
J Periodontol
, vol.66
, pp. 572-578
-
-
Nery, E.B.1
Fdson, R.G.2
Lee, K.K.3
Pruthi, V.K.4
Watson, J.5
-
7
-
-
0027463339
-
The prevalence and severity of cyclosporine and nifedipine-induced gingival overgrowth
-
Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporine and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993; 20: 37-40
-
(1993)
J Clin Periodontol
, vol.20
, pp. 37-40
-
-
Thomason, J.M.1
Seymour, R.A.2
Rice, N.3
-
8
-
-
0030139665
-
Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model
-
Nishikawa S, Nagata T, Morisaki I, Oka T, Ishida H. Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model. J Periodontol 1996; 67: 463-471
-
(1996)
J Periodontol
, vol.67
, pp. 463-471
-
-
Nishikawa, S.1
Nagata, T.2
Morisaki, I.3
Oka, T.4
Ishida, H.5
-
9
-
-
0028331310
-
Resolution of cyclosporin-induced gingival hypertrophy with metronidazole
-
Wong W, Hodge MG, Lewis A, Sharpstone P, Kingswood JC. Resolution of cyclosporin-induced gingival hypertrophy with metronidazole. Lancet 1994; 343: 986
-
(1994)
Lancet
, vol.343
, pp. 986
-
-
Wong, W.1
Hodge, M.G.2
Lewis, A.3
Sharpstone, P.4
Kingswood, J.C.5
-
10
-
-
0023606567
-
Cyclosporin and gingival overgrowth
-
Bartold PM. Cyclosporin and gingival overgrowth. J Oral Pathol 1987; 16: 463-468
-
(1987)
J Oral Pathol
, vol.16
, pp. 463-468
-
-
Bartold, P.M.1
-
11
-
-
0029070453
-
A risk-benefict assesment of tacrolimus in transplantation
-
Winkler M, and Christians U. A risk-benefict assesment of tacrolimus in transplantation. Drug Safety 1995; 12: 348-357
-
(1995)
Drug Safety
, vol.12
, pp. 348-357
-
-
Winkler, M.1
Christians, U.2
-
12
-
-
0023054577
-
Gingival hyperplasia associated with nifedipine
-
Jones CM. Gingival hyperplasia associated with nifedipine. Br Dent J 1986; 160: 416-417
-
(1986)
Br Dent J
, vol.160
, pp. 416-417
-
-
Jones, C.M.1
-
13
-
-
0023244165
-
Gingival hyperplasia caused by nifedipine
-
Barak S, Engelberg IS, Hiss J. Gingival hyperplasia caused by nifedipine. J Periodontol 1987; 58: 639-642
-
(1987)
J Periodontol
, vol.58
, pp. 639-642
-
-
Barak, S.1
Engelberg, I.S.2
Hiss, J.3
-
14
-
-
0028209890
-
Nifedipine aggravates cyclosporine A-induced gingival hyperplasia
-
Bökenkamp A, Bahuharst B, Beier C, Albers N, Offner G, Brondehl J. Nifedipine aggravates cyclosporine A-induced gingival hyperplasia. Pediatr Nephrol 1994; 8: 181-185
-
(1994)
Pediatr Nephrol
, vol.8
, pp. 181-185
-
-
Bökenkamp, A.1
Bahuharst, B.2
Beier, C.3
Albers, N.4
Offner, G.5
Brondehl, J.6
-
15
-
-
0030279506
-
Azithromycin in the treatment of periodontal disease. Effect on microbial flora
-
Sefton AM, Maskell JP, Beighton D et al. Azithromycin in the treatment of periodontal disease. Effect on microbial flora. J Clin Periodontol 1996; 23: 995-1003
-
(1996)
J Clin Periodontol
, vol.23
, pp. 995-1003
-
-
Sefton, A.M.1
Maskell, J.P.2
Beighton, D.3
-
16
-
-
0025345595
-
Intracellular accumulation of azithromycin by cultured human fibroblasts
-
Glaude RP, Snider ME. Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob Agents Chemother 1990; 34: 1056-1060
-
(1990)
Antimicrob Agents Chemother
, vol.34
, pp. 1056-1060
-
-
Glaude, R.P.1
Snider, M.E.2
-
17
-
-
0026317665
-
Study of the effects of the drug FK506 on gingival tissues
-
Adams CKS, Famili PA. Study of the effects of the drug FK506 on gingival tissues. Transplant Proc 1991; 23: 3193-3194
-
(1991)
Transplant Proc
, vol.23
, pp. 3193-3194
-
-
Adams, C.K.S.1
Famili, P.A.2
-
18
-
-
0028124324
-
Randomised trial comparing tacrolimus (Fk506) and cyclosporin in prevention of liver allograft rejection
-
Neuhaus P, Pichmayr R, Williams R, and the European FK506 Liver Study Group. Randomised trial comparing tacrolimus (Fk506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423-428
-
(1994)
Lancet
, vol.344
, pp. 423-428
-
-
Neuhaus, P.1
Pichmayr, R.2
Williams, R.3
-
19
-
-
0027199448
-
Induction of transforming growth factor-β during cardiac allograft rejection
-
Waltenberger J, Wonders A, Fellström B, Miyazono K, Heldin CH, Funa K. Induction of transforming growth factor-β during cardiac allograft rejection. J Immunol 1993; 151: 1147-1157
-
(1993)
J Immunol
, vol.151
, pp. 1147-1157
-
-
Waltenberger, J.1
Wonders, A.2
Fellström, B.3
Miyazono, K.4
Ch, H.5
Funa, K.6
-
20
-
-
0028108801
-
Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP 12
-
Wang T, Donahoe PK, Zervos AS. Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP 12. Science 1994; 265: 674-676
-
(1994)
Science
, vol.265
, pp. 674-676
-
-
Wang, T.1
Donahoe, P.K.2
Zervos, A.S.3
-
21
-
-
0030279002
-
Immunohistochemical localization of transforming growth factor β, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phentoin
-
Saito K, Mori S, Iwakura M, Sakamoto S. Immunohistochemical localization of transforming growth factor β, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phentoin. J Periodontol 1996; 31: 545-555
-
(1996)
J Periodontol
, vol.31
, pp. 545-555
-
-
Saito, K.1
Mori, S.2
Iwakura, M.3
Sakamoto, S.4
-
22
-
-
0023251118
-
Cyclosporin, nifedipin and gingival hyperplasia
-
Slavin J, Taylor J. Cyclosporin, nifedipin and gingival hyperplasia. Lancet 1987; 2: 739
-
(1987)
Lancet
, vol.2
, pp. 739
-
-
Slavin, J.1
Taylor, J.2
-
23
-
-
9844248848
-
Verapamil and cyclosporine-induced gingival overgrowth
-
Cebeci I, Kantorci A, Firatli E, Çarin M, and Tuncer Ö. Verapamil and cyclosporine-induced gingival overgrowth. J Periodontol 1993; 67: 1201-1205
-
(1993)
J Periodontol
, vol.67
, pp. 1201-1205
-
-
Cebeci, I.1
Kantorci, A.2
Firatli, E.3
Çarin, M.4
Tuncer, Ö.5
|